glp 1 abbreviation medical The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 Prescription GLP-1s for Weight Loss

Author Contributions Kayla Parsons: writing original draft (lead), writing review and editing (equal)

Meanwhile, according to a 2026 study, patients in the dataset who took Wegovy were 4.74 times more likely to develop ION (Ischemic optic neuropathy) than those who took another brand of GLP-1 drugs

Lack of confirmation of actual drug intake limits the ability to draw conclusions about long-term effects on sexual health

doi: 10.1038/s41598-023-47217-2

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers